Tag: Corbevax

Biological E has received the Drugs Controller General of Indias' (DCGI) approval for conducting Phase 3 comparator safety and immunogenicity trial of its Corbevax vaccine in adults after the subject expert committee's (SEC) review of Phase 1 and 2 clinical trials data.

Despite a pickup in second dose vaccination rate in Odisha, with an average of around 35k per day, the State will take a massive 829 days to fully vaccinate the targeted 3.1 cr population. From Aug 15, likely roll out of Corbevax in State